HOLX Stock Summary and Trading Ideas (Hologic | NASDAQ:HOLX)

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Hologic trades on the NASDAQ stock market under the symbol HOLX.

As of May 14, 2024, HOLX stock price climbed to $75.58 with 72,294 million shares trading.

HOLX has a beta of 0.80, meaning it tends to be less sensitive to market movements. HOLX has a correlation of 0.28 to the broad based SPY ETF.

HOLX has a market cap of $17.74 billion. This is considered a Large Cap stock.

Last quarter Hologic reported $1 billion in Revenue and $1.03 earnings per share. This beat revenue expectation by $18 million and exceeded earnings estimates by $.05.

In the last 3 years, HOLX stock traded as high as $87.88 and as low as $59.78.

The top ETF exchange traded funds that HOLX belongs to (by Net Assets): VTI, VOO, VO, SPY, IVV.

HOLX has underperformed the market in the last year with a price return of -8.7% while the SPY ETF gained +28.4%. HOLX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +3.2% and -1.4%, respectively, while the SPY returned +5.9% and +2.3%, respectively.

HOLX support price is $74.79 and resistance is $76.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HOLX stock will trade within this expected range on the day.